Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

679 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Exploiting tumour hypoxia in cancer treatment.
Brown JM, Wilson WR. Brown JM, et al. Among authors: wilson wr. Nat Rev Cancer. 2004 Jun;4(6):437-47. doi: 10.1038/nrc1367. Nat Rev Cancer. 2004. PMID: 15170446 Review. No abstract available.
Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs.
Hunter FW, Young RJ, Shalev Z, Vellanki RN, Wang J, Gu Y, Joshi N, Sreebhavan S, Weinreb I, Goldstein DP, Moffat J, Ketela T, Brown KR, Koritzinsky M, Solomon B, Rischin D, Wilson WR, Wouters BG. Hunter FW, et al. Among authors: wilson wr. Cancer Res. 2015 Oct 1;75(19):4211-23. doi: 10.1158/0008-5472.CAN-15-1107. Epub 2015 Aug 21. Cancer Res. 2015. PMID: 26297733
Targeting hypoxia in cancer therapy.
Wilson WR, Hay MP. Wilson WR, et al. Nat Rev Cancer. 2011 Jun;11(6):393-410. doi: 10.1038/nrc3064. Nat Rev Cancer. 2011. PMID: 21606941 Review.
679 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page